Inventiva Pharma

📍 Daix, France🗓 Founded 2012👥 114 employees💰 Last funded May 2022
Biotechnology Research🌐 inventivapharma.com
Website LinkedIn
Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology. Our research and development programs target indications with substantial unmet medical needs: NASH, MPS and oncology.
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2012
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
France
1
Frequently asked questions
Who invested in Inventiva Pharma?
Inventiva Pharma has 2 investors on record on gritt.io and 2 late-stage investors.
When did Inventiva Pharma last raise funding?
The most recent investment in Inventiva Pharma recorded on gritt.io was in May 2022.
When was Inventiva Pharma founded?
Inventiva Pharma was founded in 2012.
What industry is Inventiva Pharma in?
Inventiva Pharma operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Inventiva Pharma based?
Inventiva Pharma is headquartered in Daix, France.